To our knowledge, this is the first study to demonstrate that anti-EGFR mAbs and checkpoint inhibitors are responsible for the induction of the cytoprotective mechanism of autophagy in CRC cell lines bearing BRAFV600E. Here, EGFR is linked to colorectal carcinoma.